Our Genetic Toxicology unit offers a comprehensive suite of genotoxicity screening and OECD regulatory tests to support the pharmaceutical, biotech, and chemical industries. As specialists, we provide both in vitro and in vivo assays, including Ames tests, micronucleus tests, mouse lymphoma tests and transgenic rodent somatic and germ cell mutation analysis.
Our expertise extends to assessing DNA damage, mutations, and chromosomal alterations across a variety of compounds and materials. With a strong focus on GLP-compliant studies and regulatory submission support, Scantox is the preferred partner for companies aiming to ensure the safety and regulatory compliance of their products. Our validated testing protocols and extensive experience in genotoxicity testing make us the first choice for thorough and reliable genetic toxicity assessments.
Why Scantox
- Customer satisfaction is our absolute priority
- Your timeline is our timeline
- Every study is custom-built
- Scientific input to study design and data interpretation
- Extensive experience with virtually all drug targets and treatment types
- Wide range of validated models and techniques for comprehensive compound tests from a single source
- Highest degree of animal welfare and quality standards
